MEDP vs XYL · P/E 25, rev $707.3M vs P/E 27, rev $4.46B
Medpace Holdings Inc (MEDP) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
MEDP currently screens at market cap $9.30B and trailing P/E 24.7. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the MEDP and XYL stock pages for the full models.
Not investment advice.